As of 2025-07-13, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -9.00 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.26 USD, the upside of Solid Biosciences Inc is -271.19%.
Based on its market price of 5.26 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 271.19%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.00 - -9.00 | -9.00 | -271.19% |
| P/E | (19.02) - (34.00) | (25.03) | -575.9% |
| DDM - Stable | (17.14) - (55.73) | (36.44) | -792.7% |
| DDM - Multi | (0.29) - (0.72) | (0.41) | -107.8% |
| Market Cap (mil) | 407.76 |
| Beta | 2.25 |
| Outstanding shares (mil) | 77.52 |
| Enterprise Value (mil) | 198.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.13% |
| Cost of Debt | 5.00% |
| WACC | 9.11% |